Dollex Agrotech Financial Trend Shows Negative Shift in Q3 2025 Performance

Nov 19 2025 08:01 AM IST
share
Share Via
Dollex Agrotech, a player in the Fertilizers sector, has experienced a notable change in its financial trend for the quarter ending September 2025. The company’s recent quarterly data reveals a shift from a previously flat financial trend to a negative one, reflecting adjustments in key performance metrics compared to its historical averages over the last four quarters.



In the quarter under review, Dollex Agrotech reported net sales of ₹53.12 crores, which shows a decline of 9.8% relative to its average sales in the preceding four quarters. This contraction in sales volume is accompanied by a significant change in profitability indicators. The profit before tax excluding other income (PBT LESS OI) stood at ₹0.39 crores, marking a reduction of 82.2% compared to the previous four-quarter average. Similarly, the profit after tax (PAT) for the quarter was ₹0.36 crores, reflecting a 77.0% decrease against the same benchmark.




Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!



  • Recently turned profitable

  • Strong business fundamentals

  • Pre-breakout opportunity


Catch the Breakout Early →




Market performance for Dollex Agrotech over recent periods shows modest returns relative to the broader Sensex index. The stock recorded a 0.12% gain over the past week and month, while the Sensex posted gains of 0.84% and 0.78% respectively during the same periods. Year-to-date, Dollex Agrotech’s return stands at 7.33%, trailing the Sensex’s 9.58%. Over the last year, the stock’s return was 1.36%, compared with the Sensex’s 10.47%. Longer-term returns for three, five, and ten years are not available for Dollex Agrotech, whereas the Sensex has delivered 41.53%, 100.26%, and 235.11% respectively over these periods.



The stock price of Dollex Agrotech closed at ₹41.00, marginally above the previous close of ₹40.95. The intraday trading range saw a low of ₹39.00 and a high of ₹41.60. The stock’s 52-week price range spans from ₹32.00 to ₹44.25, indicating a relatively narrow trading band in the past year.




Is Dollex Agrotech your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!



  • Better alternatives suggested

  • Cross-sector comparison

  • Portfolio optimization tool


Find Better Alternatives →




Dollex Agrotech’s recent adjustment in its financial trend parameter from flat to negative reflects a revision in its evaluation score, which has implications for investors analysing the company’s short-term financial health. The company’s Mojo Score currently stands at 47.0, with a grade adjustment noted on 17 Nov 2025, shifting from Hold to Sell. This change is linked to the financial trend parameter update triggered on 19 Nov 2025.



While the company’s market capitalisation grade remains at 4, indicating a moderate market cap size within its sector, the recent quarterly results highlight challenges in sustaining revenue growth and margin stability. The contraction in profitability metrics such as PBT and PAT relative to historical averages suggests operational pressures or market conditions impacting the Fertilizers sector player.



Investors should consider these financial trend changes in the context of broader sector dynamics and market conditions. The Fertilizers industry often faces cyclical demand influenced by agricultural cycles, input costs, and regulatory factors, which may contribute to fluctuations in company performance. Comparing Dollex Agrotech’s returns with the Sensex benchmark underscores the stock’s relative underperformance over multiple time frames, which may be a factor in portfolio allocation decisions.



Overall, the data indicates a period of adjustment for Dollex Agrotech, with recent quarterly performance deviating from prior trends. Stakeholders analysing the company’s financial health should monitor upcoming quarterly disclosures and sector developments to better understand the trajectory of its business fundamentals and market positioning.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News